Section 16B-13-3 - Opioid treatment programs to obtain license; application; fees and inspections(a) No person, partnership, association, or corporation may operate an opioid treatment program without first obtaining a license from the director in accordance with the provisions of this article and the rules lawfully promulgated pursuant to this article.(b) Any person, partnership, association, or corporation desiring a license to operate an opioid treatment program in this state shall file with the Office of Health Facility Licensure and Certification an application in such form and with such information as the director shall prescribe and furnish accompanied by an application fee.(c) The Director of the Office of Health Facility Licensure and Certification or his or her designee shall inspect each facility and review all documentation submitted with the application. The director shall then approve or deny the application for a license. The director shall issue a license if the facility is in compliance with the provisions of this article and with the rules lawfully promulgated pursuant to this article.(d) A license shall be issued in one of three categories: (1) An initial 12 month license shall be issued to an opioid treatment program establishing a new program or service for which there is insufficient consumer participation to demonstrate substantial compliance with this article and with all rules promulgated pursuant to this article;(2) A provisional license shall be issued when an opioid treatment program seeks a renewal license, or is an existing program as of the effective date of this article and is seeking an initial license, and the opioid treatment program is not in substantial compliance with this article and with all rules promulgated pursuant to this article, but does not pose a significant risk to the rights, health and safety of a consumer. It shall expire not more than six months from the date of issuance, and may not be consecutively reissued; or(3) A renewal license shall be issued when an opioid treatment program is in substantial compliance with this article and with all rules promulgated pursuant to this article. A renewal license shall expire not more than one year from the date of issuance.(e) At least 60 days prior to the license expiration date, an application for renewal shall be submitted by the opioid treatment program to the director on forms furnished by the director. A license shall be renewed if the director determines that the applicant is in compliance with this article and with all rules promulgated pursuant to this article. A license issued to one program location pursuant to this article is not transferrable or assignable. Any change of ownership of a licensed medication-assisted treatment program requires submission of a new application. The medication-assisted treatment program shall notify the director of any change in ownership within 10 days of the change and must submit a new application within the time frame prescribed by the director.(f) Any person, partnership, association, or corporation that seeks to obtain or renew a license for an opioid treatment program in this state must submit to the director the following documentation: (1) Full operating name of the program as advertised;(2) Legal name of the program as registered with the West Virginia Secretary of State;(3) Physical address of the program;(4) Preferred mailing address for the program;(5) Email address to be used as the primary contact for the program;(6) Federal Employer Identification Number assigned to the program;(7) All business licenses issued to the program by this state, the State Tax Department, the Secretary of State and all other applicable business entities;(8) Brief description of all services provided by the program;(10) Legal Registered Owner Name - name of the person registered as the legal owner of the program. If more than one legal owner (i.e., partnership, corporation, etc.) list each legal owner separately, indicating the percentage of ownership;(11) Medical director's full name, medical license number, Drug Enforcement Administration registration number, and a list of all current certifications;(12) For each employee of the program, provide the following: (A) Employee's role and occupation within the program;(C) Medical license, if applicable;(D) Drug Enforcement Administration registration number, if applicable;(E) Drug Enforcement Administration identification number to prescribe buprenorphine for addiction, if applicable; and(F) Number of hours per week worked at program;(13) Name and location address of all programs owned or operated by the applicant;(14) Notarized signature of applicant;(15) Check or money order for licensing fee and inspection fee;(16) Verification of education and training for all physicians, counselors and social workers practicing at or used by referral by the program such as fellowships, additional education, accreditations, board certifications and other certifications;(17) Board of Pharmacy Controlled Substance Prescriber Report for each prescriber practicing at the program for the three months preceding the date of application; and(18) If applicable, a copy of a valid Certificate of Need or a letter of exemption from the West Virginia Health Care Authority.(g) Upon satisfaction that an applicant has met all of the requirements of this article, the director shall issue a license to operate an opioid treatment program. An entity that obtains this license may possess, have custody, or control of, and dispense drugs indicated and approved by the United States Food and Drug Administration for the treatment of substance use disorders.(h) The opioid treatment program shall display the current license in a prominent location where services are provided and in clear view of all patients.(i) The director or his or her designee shall inspect on a periodic basis all opioid treatment programs that are subject to this article and all rules adopted pursuant to this article to ensure continued compliance.Added by 2024 Acts, ch. TBD (SB 300), eff. 2/8/2024.